NCT lookup

Pull any trial record directly from ClinicalTrials.gov.

Trifecta Research Study

Active Not RecruitingN/A

Sponsor: Axial Therapeutic Research

Conditions: PTSD - Post Traumatic Stress Disorder, Cognitive Dysfunction, Brain Injury, Depression - Major Depressive Disorder, Suicidal Ideation

Interventions: Magnetic e-Resonance Therapy (MeRT), Ibogaine Hydrochloride with Magnesium Sulfate, 5-methoxy-N,N-dimethyltryptamine, Physiological Supplementation

Countries: United States

This observational study evaluates the impact of Ibogaine-Magnesium (IM), 5-methoxy-N,N-dimethyltryptamine (5-MeO-DMT), Magnetic e-Resonance Therapy (MeRT), and Physiological Supplementation (PS) on posttraumatic stress disorder (PTSD) and traumatic brain injury-related cognitive symptoms among Special Operations Forces (SOF) combat veterans.

Eligibility overview

Sex: ALL

Age: 18 Years to —

Healthy volunteers: Yes

Study type: OBSERVATIONAL

Eligibility criteria

Inclusion Criteria:

* At least 18 years of age
* Sponsored by SOC-F Program

Exclusion Criteria (evaluated by SOC-F, not Axial Therapeutic Research):

* Diagnosis of Schizophrenia, Bipolar I or II disorder for which patient has been hospitalized or medicated, Depersonalization and/or Derealization Disorder
* Cerebellar dysfunction, Epilepsy, Psychosis or acute confusional state, Dementia
* Prolonged corrected QT interval (QTc) Interval (450ms in males; 470ms in females)
* History of heart failure or hypertrophic heart
* Active blood clots (e.g., Pulmonary embolism, Deep vein thrombosis)
* Major respiratory conditions (e.g., Emphysema, Cystic fibrosis)
* Severe chronic gastrointestinal issues (e.g., bleeding ulcer, leaky gut syndrome)
* Within 6 months of surgeries
* Abnormal blood test results (e.g., potassium or magnesium outside normal range)
* Impaired kidney or liver function
* Refusal to taper off of selective serotonin reuptake inhibitor (SSRI) medication

Locations (1)

Northridge, California, United States